Sentences with phrase «from unfavorable»

Adding a Hartford renters insurance plan can give you one more way to protect yourself from unfavorable financial circumstances that could come up in the lives of renters anywhere.

Aside from unfavorable economic conditions, the biggest reason for the radical changes in ROP coming with the new year is something few people have heard of outside the insurance industry — it's called Actuarial Guideline 45.

Workplace discrimination and harassment occur when an employee suffers from unfavorable, unfair or unwelcome treatment in the workplace.

However, because calculating the true value of your claim can be complex, it can be difficult to recognize a fair offer from an unfavorable offer.

«What's especially concerning about this current northern fur seal crisis is that this species has a particularly difficult time recovering from unfavorable ocean conditions, such as these warmer waters,» says Tenaya Norris, marine scientist at The Marine Mammal Center.

When it's clear that your puppy is biting playfully, it's important to redirect her away from this unfavorable behavior toward an acceptable way to play.

REIT funds may be subject to other risks including, but not limited to, changes in real estate values or economic conditions, credit risk and interest rate fluctuations and changes in the value of the underlying property owned by the trust and defaults by borrowers.In addition to normal risks associated with equity investing, international investing may involve risk of capital loss from unfavorable fluctuations in currency values, from differences in generally accepted accounting principles, and from adverse political, social and economic instability in other nations.

And in all but the most favorable valuation environments, retirees should consider more defensive bond allocations — i.e., bills as opposed to longer - term bonds — as even with valuation - based adjustments, stock / bond portfolios underperformed stock / bills portfolios from unfavorable and moderate starting valuations.

International investments may also involve risk from unfavorable fluctuation in currency values, differences in generally accepted accounting principles and economic or political instability.

Because of the dollar cost averaging during the first twenty years, the market went from unfavorable valuations, as it is today, to favorable, as it will be in the future.

Such secures and protects them from unfavorable market conditions that can considerably lessen the value of the contracts prior to starting withdrawing money from the account.

International investments may involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability.

Unlike most of the movies that set records for box office futility, Mars did not get ice cold reviews, instead drawing a mixed bag critically, though most assessments spanned from unfavorable to muted approval.

Why are so many women suffering from unfavorable symptoms even through their doctors say their blood work is fine?

To stabilize yield from these unfavorable areas, Thailand and IRRI established a joint research and training facility for deepwater rice — the Prachinburi Rice Research Center — in 1974.

In addition to normal risks associated with equity investing, international investing may involve risk of capital loss from unfavorable fluctuations in currency values, from differences in generally accepted accounting principles, and from adverse political, social and economic instability in other nations.

As of last week, the Market Climate for stocks was characterized by unusually unfavorable valuations, and market action so tenuous that it is indistinguishable from unfavorable action.

Not exact matches

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Regulators have generally held an unfavorable view of shrinking the US mobile carrier market from 4 to 3, a move that government entities have claimed will reduce much - needed competition.

The Republican presidential frontrunner said his attendance in recent years resulted in various unfavorable reports regarding his perceived inability to take a joke, so Trump will skip the dinner later this month, to be hosted by The Nightly Show host Larry Wilmore, despite receiving numerous invitations from media groups.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Another, RemoveMyName.com, claimed it can «attempt to remove» unfavorable or false reviews from Angie's List, the outlet reports.

The company reported earnings and revenue for the first quarter that were roughly in line with consensus estimates, but did not provide much new color on an unfavorable tax allowance decision from federal regulators.

Prior research has shown that the use of social media may detract from face - to - face relationships, reduce investment in meaningful activities, increase sedentary behavior by encouraging more screen time, lead to internet addiction, and erode self - esteem through unfavorable social comparison.

Then there was $ 14 million in «unfavorable impact» attributable to tax items related to the separation from MetLife, Brighthouse said.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

Returns from global stocks during the period from November 2002 to May 2015 showed that stocks with favorable readings in these three descriptors persistently outperformed those with unfavorable readings.

Adjusted EBITDA growth was driven by gains from cost savings initiatives and favorable pricing net of higher local input costs that were partially offset by unfavorable volume / mix.

The investment manager generally will increase the exposure of the Fund to interest rate risk in environments where the return expected to be derived from that risk is high, and generally will reduce exposure to interest rate risk when the return expected to be derived from that risk is unfavorable.

Even last year, we discovered new tools that allowed us to re-classify a small but important set of historical observations from «unfavorable» to «favorable», based on breadth momentum and interest rate trends.

United States Segment Adjusted EBITDA increased 3.2 percent versus the year - ago period to $ 1.6 billion, driven by gains from cost savings initiatives that were partially offset by unfavorable key commodity (3) costs, particularly in cheese and coffee, as well as lower net sales.

These risks and uncertainties include food safety and food - borne illness concerns; litigation; unfavorable publicity; federal, state and local regulation of our business including health care reform, labor and insurance costs; technology failures; failure to execute a business continuity plan following a disaster; health concerns including virus outbreaks; the intensely competitive nature of the restaurant industry; factors impacting our ability to drive sales growth; the impact of indebtedness we incurred in the RARE acquisition; our plans to expand our newer brands like Bahama Breeze and Seasons 52; our ability to successfully integrate Eddie V's restaurant operations; a lack of suitable new restaurant locations; higher - than - anticipated costs to open, close or remodel restaurants; increased advertising and marketing costs; a failure to develop and recruit effective leaders; the price and availability of key food products and utilities; shortages or interruptions in the delivery of food and other products; volatility in the market value of derivatives; general macroeconomic factors, including unemployment and interest rates; disruptions in the financial markets; risk of doing business with franchisees and vendors in foreign markets; failure to protect our service marks or other intellectual property; a possible impairment in the carrying value of our goodwill or other intangible assets; a failure of our internal controls over financial reporting or changes in accounting standards; and other factors and uncertainties discussed from time to time in reports filed by Darden with the Securities and Exchange Commission.

Adjusted EBITDA increased 0.7 percent versus the year - ago period to $ 2.1 billion, despite an unfavorable 1.2 percentage point impact from currency.

Net sales were $ 6.7 billion, down 1.7 percent versus the year - ago period, including an unfavorable 0.8 percentage point impact from currency.

Canada Segment Adjusted EBITDA decreased 1.2 percent versus the year - ago period to $ 189 million, including an unfavorable 3.5 percentage point impact from currency.

Rest of World Segment Adjusted EBITDA decreased 11.6 percent versus the year - ago period to $ 180 million, including an unfavorable 3.0 percentage point impact from currency.

Declining gold prices and the perception of an unfavorable permitting environment at that time discouraged Atlas from developing the project, and the property was optioned to Newmont Exploration Ltd (Newmont) in 1992.

Meanwhile, the most unfavorable comparisons for a risk - managed investment approach are always when the market has moved from trough - to - peak in an already overvalued market.

Bulls have emerged in defense of Celgene Corporation (NASDAQ: CELG) as the sell - off continues after unfavorable news from the U.S. Food and Drug Administration.

The $ 20 million of revenue reportability was driven by $ 9 million of favorable revenue reportability in the first quarter of 2011, due to year - end 2010 sales associated with the launch of the company's Marriott Vacation Club Destinations program that were recognized during the first quarter of 2011, and $ 11 million of unfavorable revenue reportability in the current year quarter from strong contract sales growth that resulted in an increase in contract sales in rescission periods at the end of the quarter.

In the firm's construction products segment, for instance, sales in western Europe dropped 27 percent as a result of unfavorable exchange rates, a «weak» construction environment and Grace's exit from «low - margin business.»

The $ 9 million of revenue reportability included $ 3 million of favorable revenue reportability in the second quarter of 2011 compared to $ 6 million of unfavorable revenue reportability in the current year quarter resulting from certain financed sales not having met the downpayment requirement for revenue recognition purposes by the end of the quarter.

Revenue from the sale of vacation ownership products increased $ 5 million to $ 122 million in the second quarter, driven mainly by the $ 13 million increase in contract sales, partially offset by $ 9 million of unfavorable year - over-year revenue reportability.

As of last week, the Market Climate for stocks was characterized by unusually unfavorable valuations and unfavorable market action (a deterioration from the prior week, primarily on the basis of interest - sensitive securities such as bonds and utilities, as well as measures of breadth and distribution).

For instance, you forgot to exit from an open trade and the tide has turned unfavorable, in that case, the trade will continue till you may lose the total amount available for the trading in your account.

The father of client - centered counseling states clearly that many troubled people can not benefit from an insight - oriented, client - centered approach because of excessive instability, aging, or unfavorable environment.

Are favorable mutations abundant enough to provide, in the time available, the variations which natural selection would require (mutations from ionizing radiations appearing to be both too rare and too predominantly unfavorable)?

Perhaps it was the enthusiasm of Galilean pilgrims, who hailed him as Messiah as he entered the city, which called Jesus to the unfavorable notice of the Roman authorities; perhaps it was Jesus» own act of driving money - changers from the temple courts; perhaps it was the bringing of charges against him by powerful Jewish groups whom he had offended.

Nowadays more and more deviation from these conceptions concerning favorable and unfavorable times is evident.

With support from various agencies of the DA and from the International Rice Research Institute, the project aims to enhance the productivity of and enrich the legacy of heirloom or traditional rice through empowered indigenous communities in unfavorable rice - based ecosystems.